NAFLD, Nutrient; Excess
Conditions
Brief summary
In health,adipose tissue stores fat from the diet. If the fat tissue stops storing dietary fat then this increases the chance of it being stored in the liver, which is related to increased risk of heart disease and type 2 diabetes. It has been suggested that having a diet high in sugars or certain fats, may cause the fat tissue and liver to change how they function; we would like to investigate this in detail.
Detailed description
This research aims to investigate how the overconsumption of specific macronutrients may effect adipose tissue and liver metabolism and function. Liver and heart fat content and adipose tissue and liver metabolism fasting and postprandial lipid metabolism will be assessed before and after the specific dietary intervention.
Interventions
OTHEROverconsumption of specific dietary nutrient
Subjects will be studied before and then after the consumption of a diet where specific nutrients are provided in excess.
Sponsors
University of Oxford
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged ≥18 or ≤65 years. * Body Mass Index ≥19 ≤35 kg/m2 * No medical condition or relevant drug therapy known to affect liver or adipose tissue metabolism. * Weight stable for the previous 3 months
Exclusion criteria
* Patient is unwilling or unable to give informed consent for participation in the study * A blood haemoglobin \<135mg/dL for men and \<120mg/dL for women * Donated (or lost) ≥250 ml of blood in the previous two months. * On a weight loss diet or have decreased their body weight by \>5% in the previous 3 months. * Have increased their body weight by \>5% in the previous 3 months. * Any metabolic condition or relevant drug therapy * Current smoker * History of alcoholism or a greater than recommended alcohol intake (\>30 g of alcohol daily for men and \>20 g of alcohol daily for women) * Haemorrhagic disorders * Anticoagulant treatment * History of albumin allergy * Pregnant or nursing mothers * Women who are taking any contraceptive agent or device including oral contraceptives, hormone replacement therapy (HRT) or who have used these within the last 12 months * History of severe claustrophobia * Presence of metallic implants, pacemaker, or are unwilling to remove any piercings * History of an eating disorder or any other psychological condition that may affect the participants ability to adhere to study intervention/experimental diets.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Liver de novo lipogenesis | Within 21 days after starting the intervention diet | Investigators will utilise stable isotope tracer methodology to measure the change in the contribution of newly synthesised fatty acids to very low density lipoprotein triglyceride |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adipose tissue metabolism | Within 21 days after starting the intervention diet | Investigators will measure the change in the expression of key lipogenic genes in subcutaneous adipose tissue |
| Liver fat accumulation | Within 21 days after starting the intervention diet | Investigators will measure the change in the amount of fat within the liver using MRI/S |
Countries
United Kingdom
Contacts
Primary ContactLeanne Hodson, PhD
Outcome results
None listed